Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?
Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury: JACC State-of-the-Art Review
Older Adults in the Cardiac Intensive Care Unit: Factoring Geriatric Syndromes in the Management, Prognosis, and Process of Care: A Scientific Statement From the American Heart Association
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association